Insider Transactions in Q1 2022 at Cue Biopharma, Inc. (CUE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
735,000
+50.0%
|
$2,940,000
$4.76 P/Share
|
|
Mar 31
2022
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
10,000
-7.06%
|
-
|
|
Mar 31
2022
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
32,122
-18.49%
|
$128,488
$4.88 P/Share
|
|
Mar 31
2022
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+30.16%
|
-
|
|
Mar 31
2022
|
Anish Suri PRESIDENT AND CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,068
-6.38%
|
$28,272
$4.88 P/Share
|
|
Mar 31
2022
|
Anish Suri PRESIDENT AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,668
+13.09%
|
-
|